Carregant...
Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis
The growing pipeline of candidate drugs for cystic fibrosis (CF) is challenging clinical trial research. There has been a shift from evaluating drugs aimed at treating the secondary manifestations of CF to evaluating drugs targeted toward the primary prevention of chronic lung disease. As CF is an o...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Thoracic Society
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2647602/ https://ncbi.nlm.nih.gov/pubmed/17652504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/pats.200703-040BR |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|